What is Monopar Therapeutics Inc. Common Stock's Market Cap?

Monopar Therapeutics Inc. Common Stock's Market Cap is $765.9M, based on as-reported figures from SEC (XBRL) filings.

What is Monopar Therapeutics Inc. Common Stock's Enterprise Value?

Monopar Therapeutics Inc. Common Stock's Enterprise Value is $713.1M, based on as-reported figures from SEC (XBRL) filings.

What is Monopar Therapeutics Inc. Common Stock's Revenue (TTM)?

Monopar Therapeutics Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Monopar Therapeutics Inc. Common Stock's Net Income (TTM)?

Monopar Therapeutics Inc. Common Stock's Net Income (TTM) is -$17.8M, based on as-reported figures from SEC (XBRL) filings.

What is Monopar Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Monopar Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -2.66, based on as-reported figures from SEC (XBRL) filings.

What is Monopar Therapeutics Inc. Common Stock's Net Debt?

Monopar Therapeutics Inc. Common Stock's Net Debt is -$52.8M, based on as-reported figures from SEC (XBRL) filings.

Monopar Therapeutics Inc. Common Stock (MNPR) Financial Statements

Monopar Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00J7K8DB7

XNAS · usd

114.10▼ 0.28 (-0.24%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close114.38

Day's Range113.27 – 117.61

52-Week Range41.12 – 124.82

Volume89.2K

Avg Volume232.8K

Share Statistics

Shares Outstanding

Employees22

ExchangeXNAS

Listed2019-12-19

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Monopar Therapeutics Inc. Common Stock (MNPR)

What is Monopar Therapeutics Inc. Common Stock's Market Cap?: Monopar Therapeutics Inc. Common Stock's Market Cap is $765.9M, based on as-reported figures from SEC (XBRL) filings.
What is Monopar Therapeutics Inc. Common Stock's Enterprise Value?: Monopar Therapeutics Inc. Common Stock's Enterprise Value is $713.1M, based on as-reported figures from SEC (XBRL) filings.
What is Monopar Therapeutics Inc. Common Stock's Revenue (TTM)?: Monopar Therapeutics Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Monopar Therapeutics Inc. Common Stock's Net Income (TTM)?: Monopar Therapeutics Inc. Common Stock's Net Income (TTM) is -$17.8M, based on as-reported figures from SEC (XBRL) filings.
What is Monopar Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Monopar Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -2.66, based on as-reported figures from SEC (XBRL) filings.
What is Monopar Therapeutics Inc. Common Stock's Net Debt?: Monopar Therapeutics Inc. Common Stock's Net Debt is -$52.8M, based on as-reported figures from SEC (XBRL) filings.